Roundup: WB returns as a website, XBox 360 prices drop in Asia and more
Here’s the latest action:
The WB rises from the dead with a new website — The television network, famous for launching teen-aimed shows like Buffy the Vampire Slayer and Dawson’s Creek, merged with UPN to become the CW network in 2006. But now the WB is returning as a website. And while the nerd in me is most excited about the ad-sponsored Buffy reruns, the most interesting news is that the site will also feature original content…. Continue Reading
Life sciences briefing: Tuesday, Oct. 16, 2007
Featured companies: Altair Therapeutics, ICyt Visionary Biosciences, Linkage Biosciences, Mendel Biotechnology, Rules-Based Medicine
Mendel Biotechnology raises funds for cellulosic-energy production — Hayward, Calif.-based Mendel Biotechnology, a biotech developing new varieties of switchgrass, Miscanthus and poplar for use as biofuels, raised an undisclosed sum in a new funding round. The company first drew funding from several investment firms, including ZBI Ventures, Capricorn Investment Group and CFM, and also raised additional cash from its partner Monsanto, which was already… Continue Reading
Life sciences briefing: Monday, Oct. 15, 2007
Featured companies: Biolipox, Cellpoint Diagnostics, Corum Medical, MediKeeper, Mendel Biotechnology, NanoMed, Orexo, Rules-Based Medicine, Tengion
UPDATED: Expanded the Tengion item, and that’s about it.
Tengion raises $33M for bladder regrowth — Tengion, a Norriton, Pa., biotech focused on regenerating diseased or damaged organs, raised $33 million in a third funding round. Investors included Deerfield Partners, Bain Capital, Johnson & Johnson Development, HealthCap, Quaker BioVentures, Oak Investment Partners, L Capital Partners, Horizon Technology Finance and Oxford Finance.
Tengion is working on… Continue Reading
Mendel Biotech raises fourth round for biofuels
Hayward, Calif.’s Mendel Biotechnology, an agricultural biotech, raised an undisclosed sum in a fourth round of funding, VentureWire reports (subscription required). The funding accompanied a development deal with the U.K. energy giant BP; Monsanto, a major developer of genetically modified seeds and a longtime Mendel partner, also participated.
The BP deal centers on the development of new genetically modified strains of grass that could be used to produce cellulosic ethanol. The production of ethanol from grasses… Continue Reading